Advertisement
Person › Details
Laetitia Bachelot-Fontaine (Valneva S.E. (Nasdaq: VALN, Euronext Paris: VLA))
Bachelot-Fontaine, Laetitia (Valneva 201404 Investor Relations + Communications Manager)
Organisation | Valneva S.E. (Nasdaq: VALN, Euronext Paris: VLA) | |
Group | Valneva (Group) | |
Product | vaccine | |
Product 2 | EB66® duck cell line | |
Record changed: 2023-11-15 |
Advertisement
More documents for Laetitia Bachelot-Fontaine
- [1] Valneva S.E.. (2/21/22). "Press Release: Valneva Awarded Up to £20 Million by Scottish Enterprise to Advance Vaccine Development". Saint-Herblain....
- [2] Valneva S.E.. (9/13/21). "Press Release: Valneva Receives Notice of Termination of COVID-19 Vaccine Supply Agreement by UK Government". Saint-Herblain....
- [3] Valneva S.E.. (8/23/21). "Press Release: Valneva Commences Rolling Submission to MHRA for its Inactivated, Adjuvanted COVID-19 Vaccine". Saint-Herblain....
- [4] Valneva S.E.. (1/9/20). "Press Release: Valneva Expands its Commercial Operations with the Opening of its French Commercial Office". Saint-Herblain....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top